Honoring Queen Elizabeth II for Her Dedication to Fighting Eye Disease News September, 2022 Editas Medicine Announces Positive Initial Clinical Data from Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10 News September, 2021 Ora Appoints David P. Bingaman, DVM, PhD, D. ACVO in Newly Created Chief Development Officer Position News April, 2021 Johnson & Johnson Vision Receives Approval of World's First and Only Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE® Theravision™ with Ketotifen News April, 2021 Oyster Point Pharma Submits New Drug Application to the U.S. Food and Drug Administration for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease News December, 2020 Palatin Technologies Announces Positive Results From its Phase 2 Study of PL9643 in Patients with Dry Eye Disease News December, 2020 Novaliq Announces First Patient Randomized in the Phase 3 trial ESSENCE-2 of CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease News December, 2020 Keith Lane Presents on Ora’s Endpoints at OIS Retina Innovation Showcase News September, 2020 Inspiring Business Women at Ora: A Panel Interview with Hydrogen Group News July, 2020 Novaliq Provides Development Update on CyclASol Topical Ophthalmic Solution for the Treatment of Dry Eye Disease News July, 2020 1 2 … 8 »
